Related references
Note: Only part of the references are listed.Role of GABRA2 in Moderating Subjective Responses to Alcohol
Sungwon Roh et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2011)
Pharmacogenetic Approach at the Serotonin Transporter Gene as a Method of Reducing the Severity of Alcohol Drinking
Bankole A. Johnson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
A genetic determinant of the striatal dopamine response to alcohol in men
V. A. Ramchandani et al.
MOLECULAR PSYCHIATRY (2011)
H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated risk for alcohol consumption and dependence
Elliot C. Nelson et al.
ADDICTION BIOLOGY (2010)
Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?
Markus Heilig et al.
ADDICTION BIOLOGY (2010)
Genetic Sensitivity to the Environment: The Case of the Serotonin Transporter Gene and Its Implications for Studying Complex Diseases and Traits
Avshalom Caspi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Suppression of Alcohol Preference by Naltrexone in the Rhesus Macaque: A Critical Role of Genetic Variation at the mu-Opioid Receptor Gene Locus
Christina S. Barr et al.
BIOLOGICAL PSYCHIATRY (2010)
MULTICENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE COMPARATOR AND PLACEBO-CONTROLLED TRIAL OF A CORTICOTROPIN-RELEASING FACTOR RECEPTOR-1 ANTAGONIST IN GENERALIZED ANXIETY DISORDER
Vladimir Coric et al.
DEPRESSION AND ANXIETY (2010)
A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys
Eric J. Vallender et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Human NPY Promoter Variation rs16147:T>C as a Moderator of Prefrontal NPY Gene Expression and Negative Affect
Wolfgang H. Sommer et al.
HUMAN MUTATION (2010)
Drug harms in the UK: a multicriteria decision analysis
David J. Nutt et al.
LANCET (2010)
Neurocircuitry of Addiction
George F. Koob et al.
NEUROPSYCHOPHARMACOLOGY (2010)
CRF-1 Antagonist and CRF-2 Agonist Decrease Binge-Like Ethanol Drinking in C57BL/6J Mice Independent of the HPA Axis
Emily G. Lowery et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Is Pharma Running Out of Brainy Ideas?
Greg Miller
SCIENCE (2010)
OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach
Gabor Oroszi et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Characterization of a Functional Polymorphism in the 3' UTR of SLC6A4 and its Association With Drinking Intensity
Chamindi Seneviratne et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
A Within-Group Design of Nontreatment Seeking 5-HTTLPR Genotyped Alcohol-Dependent Subjects Receiving Ondansetron and Sertraline
George A. Kenna et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Expansion of the human μ-opioid receptor gene architecture: novel functional variants
Svetlana A. Shabalina et al.
HUMAN MOLECULAR GENETICS (2009)
Interaction Between the Serotonin Transporter Gene (5-HTTLPR), Stressful Life Events, and Risk of Depression A Meta-analysis
Neil Risch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Alcohol and Global Health 1 Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
Juergen Rehm et al.
LANCET (2009)
Development of pharmacotherapies for drug addiction: a Rosetta Stone approach
George F. Koob et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Rainer Spanagel
PHYSIOLOGICAL REVIEWS (2009)
The G allele of SNP E1/A118G at the μ-opioid receptor gene locus shows genomic evidence of recent positive selection
Grace S. Y. Pang et al.
PHARMACOGENOMICS (2009)
Functional CRH variation increases stress-induced alcohol consumption in primates
Christina S. Barr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior
Stephen D. Mague et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients
Sung-Gon Kim et al.
PSYCHOPHARMACOLOGY (2009)
Modulation of brain response to emotional images by alcohol cues in alcohol-dependent patients
Jodi M. Gilman et al.
ADDICTION BIOLOGY (2008)
Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures
Dennis R. Sparta et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression
Brendon Binneman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Addiction and the brain antireward system
George F. Koob et al.
ANNUAL REVIEW OF PSYCHOLOGY (2008)
An evaluation of μ-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence
Raymond F. Anton et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use
Dorothea Blomeyer et al.
BIOLOGICAL PSYCHIATRY (2008)
Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala Crhr1 expression following a history of dependence
Wolfgang H. Sommer et al.
BIOLOGICAL PSYCHIATRY (2008)
Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults
Elisabeth B. Binder et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Why we like to drink: A functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol
Jodi M. Gilman et al.
JOURNAL OF NEUROSCIENCE (2008)
Genetic variation in human NPY expression affects stress response and emotion
Zhifeng Zhou et al.
NATURE (2008)
The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats
Peter W. Marinelli et al.
PSYCHOPHARMACOLOGY (2007)
Population-specific effects 14OAsp polymorphism at the μ-opioid receptor gene of the As (OPRM1) on HPA-axis activation
Carlos A. Hernandez-Avila et al.
PHARMACOGENETICS AND GENOMICS (2007)
Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking
Suchitra Krishnan-Sarin et al.
BIOLOGICAL PSYCHIATRY (2007)
Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response - A double-blind placebo-controlled study
Lara A. Ray et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
A key role for corticotropin-releasing factor in alcohol dependence
Markus Heilig et al.
TRENDS IN NEUROSCIENCES (2007)
Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States -: Results from the National Epidemiologic Survey on Alcohol and Related Conditions
Deborah S. Hasin et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine:: A novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism
Donald R. Gehlert et al.
JOURNAL OF NEUROSCIENCE (2007)
Association of a functional polymorphism in the μ-opioid receptor gene with alcohol response and consumption in male rhesus macaques
Christina S. Barr et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Region-specific down-regulation of Crhr1 gene expression in alcohol-preferring msP rats following ad lib access to alcohol
Anita C. Hansson et al.
ADDICTION BIOLOGY (2007)
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats
Cindy K. Funk et al.
BIOLOGICAL PSYCHIATRY (2007)
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis
Ping Wu et al.
BMC PUBLIC HEALTH (2006)
Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats
Cindy K. Funk et al.
JOURNAL OF NEUROSCIENCE (2006)
Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure
David H. Epstein et al.
PSYCHOPHARMACOLOGY (2006)
Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress
A. C. Hansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Association of an Asn40Asp (A118G) polymorphism in the μ-opioid receptor gene with substance dependence:: A meta-analysis
Albert Arias et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Hypothalamic-pituitary-adrenocortical axis activity: A target of pharmacological anticraving treatment?
F Kiefer et al.
BIOLOGICAL PSYCHIATRY (2006)
Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples
J. Treutlein et al.
MOLECULAR PSYCHIATRY (2006)
Relevance of frequent μ-opioid receptor polymorphisms for opioid activity in healthy volunteers
J. Lötsch et al.
PHARMACOGENOMICS JOURNAL (2006)
Association between two μ-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence
HP Zhang et al.
HUMAN MOLECULAR GENETICS (2006)
Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis
C Fehr et al.
PSYCHIATRIC GENETICS (2006)
Modulation of dopamine transmission by 5HT2c and 5HT3 receptors:: A role in the antidepressant response
E Dremencov et al.
CURRENT DRUG TARGETS (2006)
Non-human primate models of inheritance vulnerability to alcohol use disorders
Christina S. Barr et al.
ADDICTION BIOLOGY (2006)
Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms
Markus Heilig et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?
M Egli
ADDICTION BIOLOGY (2005)
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior:: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist
GR Breese et al.
NEUROPSYCHOPHARMACOLOGY (2005)
The genetics of addictions: Uncovering the genes
D Goldman et al.
NATURE REVIEWS GENETICS (2005)
GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride
A Pierucci-Lagha et al.
NEUROPSYCHOPHARMACOLOGY (2005)
An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research
L Amato et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2005)
Clinical predictors of response to naltrexone in alcoholic patients:: Who benefits most from treatment with naltrexone?
G Rubio et al.
ALCOHOL AND ALCOHOLISM (2005)
Efficacy of antidepressants in substance use disorders with and without comorbid depression -: A systematic review and meta-analysis
M Torrens et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
Conceptual framework for the etiology of alcoholism: a kindling/stress hypothesis
GR Breese et al.
PSYCHOPHARMACOLOGY (2005)
Association between alcoholism and γ-amino butyric acid α2 receptor subtype in a Russian population
J Lappalainen et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2005)
Increased attributable risk related to a functional μ-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden
G Bart et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Treated and treatment-naive alcoholics come from different populations
G Fein et al.
ALCOHOL (2005)
Variations in GABRA2, encoding the α2 subunit of the GABAA receptor, are associated with alcohol dependence and with brain oscillations
HJ Edenberg et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors
DH Overstreet et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats
DJ Knapp et al.
ALCOHOL (2004)
Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals - A randomized controlled trial
BA Johnson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Allelic and haplotypic association of GABRA2 with alcohol dependence
J Covault et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
Getting closer to affective disorders:: the role of CRH receptor systems
MB Müller et al.
TRENDS IN MOLECULAR MEDICINE (2004)
A polymorphism of the μ-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans
LA Ray et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2004)
Dopamine and drug addiction: the nucleus accumbens shell connection
G Di Chiara et al.
NEUROPHARMACOLOGY (2004)
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence:: a systematic review
B Carmen et al.
ADDICTION (2004)
Corticotropin-releasing factor in brain: A role in activation, arousal, and affect regulation
SC Heinrichs et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden
G Bart et al.
MOLECULAR PSYCHIATRY (2004)
Opioid receptors
M Waldhoer et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression
GM Miller et al.
MOLECULAR PSYCHIATRY (2004)
Alcohol promotes dopamine release in the human nucleus accumbens
I Boileau et al.
SYNAPSE (2003)
Understanding US addiction physicians' low rate of naltrexone prescription
TL Mark et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
A functional polymorphism of the μ-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients
DW Oslin et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene
A Caspi et al.
SCIENCE (2003)
Brain circuitry and the reinstatement of cocaine-seeking behavior
PW Kalivas et al.
PSYCHOPHARMACOLOGY (2003)
Historical review: Opioid receptors
SH Snyder et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
COMT val158met genotype affects μ-opioid neurotransmitter responses to a pain stressor
JK Zubieta et al.
SCIENCE (2003)
Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence
GR Valdez et al.
ALCOHOL (2003)
A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI
B Knutson et al.
NEUROIMAGE (2003)
Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals
BA Johnson et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2003)
Reward craving and withdrawal relief craving: Assessment of different motivational pathways to alcohol intake
A Heinz et al.
ALCOHOL AND ALCOHOLISM (2003)
Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress
S Makino et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Neurobiology of relapse to alcohol in rats
AD Lê et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Ondansetron reduces the craving of biologically predisposed alcoholics
BA Johnson et al.
PSYCHOPHARMACOLOGY (2002)
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor1 receptor antagonist.: II.: Characterization in rodent models of stress-related disorders
G Griebel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A):: A potent and selective corticotrophin-releasing factor1 receptor antagonist.: I.: Biochemical and pharmacological characterization
D Gully et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Linkage disequilibrium between the beta frequency of the human EEG and a GABAA receptor gene locus
B Porjesz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The Mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade
GS Wand et al.
NEUROPSYCHOPHARMACOLOGY (2002)
The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence
AL Morrow et al.
BRAIN RESEARCH REVIEWS (2001)
Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression
KS Kendler et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Drug dependence, a chronic medical illness - Implications for treatment, insurance, and outcomes evaluation
AT McLellan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Childhood sexual abuse and adult psychiatric and substance use disorders in women -: An epidemiological and Cotwin control analysis
KS Kendler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Ondansetron for reduction of drinking among biologically predisposed alcoholic patients - A randomized controlled trial
BA Johnson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats
AD Lê et al.
PSYCHOPHARMACOLOGY (2000)
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression:: the first 20 patients treated
AW Zobel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2000)
Share Paper
